Literature DB >> 1448382

The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases.

A Bohle1, M Wehrmann, O Bogenschütz, C Batz, W Vogl, H Schmitt, C A Müller, G A Müller.   

Abstract

Long-term studies of all types of primary glomerulonephritis (GN) taking into consideration the major morphological and clinical findings revealed the following: 1) Endocapillary GN, post-streptococcal type has a very good prognosis when only glomerulitis is present. The prognosis is significantly worse if either interstitial inflammation with fibrosis or nephrotic syndrome (NS) is present at the time of the biopsy. 2) The prognosis of the various types of mesangioproliferative GN (IgA nephritis, non-IgA nephritis, and immunohistologically negative GN) is very good if there is only glomerulitis. The prognosis is worse for all three types when the renal cortical interstitium exhibits inflammation with fibrosis at the time of the biopsy, and is worst of all when both interstitial fibrosis (IF) and the signs of acute renal failure (ARF) are present. Of this group, the type in which there are negative immunohistological findings exhibits the best prognosis. No difference in prognosis is found between IgA nephritis and non-IgA nephritis. 3) Minimal changes GN with NS has a very good prognosis when the interstitium is not involved. The presence of interstitial inflammation and fibrosis worsens the prognosis significantly. 4) Focal sclerosing GN has a much poorer prognosis than minimal changes GN with NS, even when there is glomerulitis only (5- and 10-year renal survival rates (RSRs) of 90% and 67%, respectively). If interstitial inflammation and fibrosis are present, the prognosis is significantly worse (5- and 10-year RSRs of 84% and 55%, respectively). The prognosis is worst when both ARF and IF are present at the time of the biopsy (5- and 10-year RSRs of 56% and 46%, respectively). From the clinical side, the prognosis is significantly worse if, at the time of the biopsy, NS is present or the serum creatinine concentration is elevated to more than 1.3 mg%. 5) Chronic membranous GN has a better prognosis than focal sclerosing GN if glomerulitis only is present (5-year RSR, 88%; 10-year RSR, 77%). If the renal cortical interstitium is also involved (in the form of IF), the prognosis is significantly worse (5-year RSR, 65%; 10-year RSR, 38%). The prognosis in this disease, too, is worst when both ARF and IF are present at the time of the biopsy (5-year RSR, 38%; 10-year RSR, 25%). 6) Membranoproliferative GN has a worse prognosis than any of the types of GN so far mentioned (5-year RSR, 51%; 10-year RSR, 32%).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1448382     DOI: 10.1016/s0344-0338(11)80252-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  24 in total

1.  Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.

Authors:  R Hirschberg
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.

Authors:  Elion Hoxha; Sigrid Harendza; Hans Pinnschmidt; Ulf Panzer; Rolf A K Stahl
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-29       Impact factor: 8.237

3.  Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

Authors:  Anna Broder; Wenzhu B Mowrey; Hina N Khan; Bojana Jovanovic; Alejandra Londono-Jimenez; Peter Izmirly; Chaim Putterman
Journal:  Semin Arthritis Rheum       Date:  2017-07-14       Impact factor: 5.532

4.  CCR2 contributes to the recruitment of monocytes and leads to kidney inflammation and fibrosis development.

Authors:  Tarcio Teodoro Braga; Matheus Correa-Costa; Reinaldo Correia Silva; Mario Costa Cruz; Meire Ioshie Hiyane; Joao Santana da Silva; Katia Regina Perez; Iolanda Midea Cuccovia; Niels Olsen Saraiva Camara
Journal:  Inflammopharmacology       Date:  2017-02-06       Impact factor: 4.473

Review 5.  Immune system modulation of kidney regeneration--mechanisms and implications.

Authors:  Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2014-04-29       Impact factor: 28.314

6.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

Review 7.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 8.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

9.  Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).

Authors:  R Pichler; C M Giachelli; D Lombardi; J Pippin; K Gordon; C E Alpers; S M Schwartz; R J Johnson
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

10.  Genetical, histological, and clinical characteristics of IgA-negative mesangioproliferative glomerulopathy.

Authors:  Kazunori Owada; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-11-25       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.